Gillian Esser
Silverdale, WANPI 1598768491
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 38.9% of the total. 2025 is the largest year on record at $618, 5.8 times the $106 reported in 2019.
Across 187 payments — averaging $12.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$944
- AbbVie$342
- Therapeuticsmd, Inc.$252
- Avion Pharmaceuticals$175
- Ascend Therapeutics US, LLC$101
- Scynexis, Inc.$61
- plus $550 from 17 others
What the payments were for
- Food & beverage$2,40699%
- Gifts$181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 77 | $944 |
| AbbVie(2 entities) | 21 | $342 |
| Therapeuticsmd, Inc. | 19 | $252 |
| Avion Pharmaceuticals | 28 | $175 |
| Ascend Therapeutics US, LLC | 6 | $101 |
| Scynexis, Inc. | 2 | $61 |
| Shield Therapeutics Inc | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $56 |
| Ironwood Pharmaceuticals, Inc | 3 | $51 |
| Evofem Biosciences, Inc. | 3 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $43 |
| IBSA Pharma Inc. | 2 | $40 |
| Baxter Healthcare | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Alfasigma USA, Inc. | 2 | $31 |
| Lilly USA, LLC | 1 | $26 |
| Amgen | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $20 |
| Lupin Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $14 |
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 37 | $2,345 |
| Estradiol (Twice Weekly)Estradiol | 14 | $1,641 |
| ProgesteroneProgesterone, Micronized | 27 | $1,131 |
| Liothyronine Sodium | 26 | $786 |
| Pravastatin Sodium | 11 | $116 |
| Levothyroxine Sodium | 11 | $75 |
| Fluconazole | 14 | $68 |
| Quetiapine Fumarate | 12 | $16 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.